<DOC>
	<DOCNO>NCT00002181</DOCNO>
	<brief_summary>The purpose study see cidofovir gel ( Forvade ) safe effective treat herpes simplex patient AIDS respond acyclovir .</brief_summary>
	<brief_title>Cidofovir Treatment Herpes Simplex Patients With AIDS</brief_title>
	<detailed_description>Patients receive open-label treatment cidofovir gel .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Cidofovir</mesh_term>
	<criteria>Inclusion Criteria Patients must : AIDS diagnosis per CDC criterion . At least partially external mucocutaneous HSV infection confirm culture current outbreak . Current HSV outbreak unresponsive &gt; = 10day course acyclovir 14 gm/day po 15 mg/kg/day IV vitro resistance HSV isolate acyclovir demonstrate within 60 day study . Signed , inform consent parent legal guardian patient le 18 year age . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Evidence cervical intraepithelial neoplasia class III ( CIN III ) Pap smear ( Pap smear require within 6 month start study drug ) . Concurrent Medication : Excluded : Acyclovir , valacyclovir , famciclovir , ganciclovir , foscarnet , topical trifluride , cidofovir injection systemic topical drug antiherpes activity . Required : &gt; = 10 day course acyclovir 14 gm/day po 15mg/kg/day IV ( require confirm vitro resistance acyclovir ) .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1997</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Herpes Simplex</keyword>
	<keyword>Acyclovir</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Gels</keyword>
	<keyword>cidofovir</keyword>
</DOC>